Michio Imawari

Title: Michio Imawari: Innovator in Gamma Retinoic Acid Receptor Research

Introduction

Michio Imawari is a notable inventor based in Tochigo Prefecture, Japan. He has made significant contributions to the field of biochemistry, particularly in the study of gamma retinoic acid receptors. With a total of 4 patents to his name, Imawari's work has implications for cancer research and biological studies.

Latest Patents

Imawari's latest patents include groundbreaking research on nucleic acid encoding gamma retinoic acid receptor fusion proteins. One of his notable inventions is a novel gamma retinoic acid receptor, which is encoded for by cDNA carried on plasmid pGEM-hRARγ. This plasmid has been deposited with the American Type Culture Collection for patent purposes. Additionally, he has disclosed chimeric receptor proteins that contain at least one functional domain from the new gamma retinoic acid receptor.

Career Highlights

Throughout his career, Michio Imawari has worked with prestigious institutions such as the Sloan-Kettering Institute for Cancer Research and the Salk Institute for Biological Studies. His research has contributed to advancements in understanding receptor functions and their applications in medical science.

Collaborations

Imawari has collaborated with esteemed colleagues, including Fumimaro Takaku and Takashi Ishikawa. These partnerships have fostered innovative research and development in the field of receptor biology.

Conclusion

In summary, Michio Imawari is a distinguished inventor whose work on gamma retinoic acid receptors has paved the way for future research in biochemistry and cancer treatment. His contributions continue to influence the scientific community and enhance our understanding of receptor mechanisms.